Transcat (NASDAQ:TRNS) Reaches New 1-Year High – What’s Next?

Posted by Geri Gentry on Jun 5th, 2026

Shares of Transcat, Inc. (NASDAQ:TRNS – Get Free Report) reached a new 52-week high on Friday . The stock traded as high as $94.76 and last traded at $90.6390, with a volume of 56968 shares trading hands. The stock had previously closed at $93.24.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on TRNS. Zacks Research raised shares of Transcat from a “strong sell” rating to a “hold” rating in a report on Friday, May 15th. Weiss Ratings raised shares of Transcat from a “sell (d)” rating to a “sell (d+)” rating in a report on Thursday, May 28th. One research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $105.33.

Check Out Our Latest Research Report on TRNS

Transcat Trading Down 3.8%

The company has a market cap of $838.26 million, a price-to-earnings ratio of 155.17 and a beta of 0.71. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.33 and a quick ratio of 1.99. The firm’s fifty day moving average price is $77.70 and its 200-day moving average price is $69.46.

Transcat (NASDAQ:TRNS – Get Free Report) last announced its quarterly earnings results on Tuesday, May 26th. The scientific and technical instruments company reported $0.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.51 by $0.05. Transcat had a net margin of 1.62% and a return on equity of 5.84%. The company had revenue of $89.33 million during the quarter, compared to the consensus estimate of $89.79 million. On average, equities analysts expect that Transcat, Inc. will post 1.71 EPS for the current fiscal year.

Institutional Investors Weigh In On Transcat

Institutional investors have recently bought and sold shares of the stock. Lazard Asset Management LLC acquired a new stake in Transcat in the second quarter worth about $54,000. Tower Research Capital LLC TRC lifted its holdings in Transcat by 245.5% in the second quarter. Tower Research Capital LLC TRC now owns 1,123 shares of the scientific and technical instruments company’s stock worth $97,000 after purchasing an additional 798 shares during the period. PNC Financial Services Group Inc. lifted its holdings in Transcat by 42.7% in the third quarter. PNC Financial Services Group Inc. now owns 1,530 shares of the scientific and technical instruments company’s stock worth $112,000 after purchasing an additional 458 shares during the period. Jones Financial Companies Lllp lifted its holdings in Transcat by 79.2% in the third quarter. Jones Financial Companies Lllp now owns 1,634 shares of the scientific and technical instruments company’s stock worth $120,000 after purchasing an additional 722 shares during the period. Finally, AlphaQuest LLC lifted its holdings in Transcat by 12,915.4% in the third quarter. AlphaQuest LLC now owns 1,692 shares of the scientific and technical instruments company’s stock worth $124,000 after purchasing an additional 1,679 shares during the period. Institutional investors and hedge funds own 98.34% of the company’s stock.

About Transcat

(Get Free Report)

Transcat, Inc (NASDAQ: TRNS) is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.

In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.